Axillary Lymph Nodes and Breast Cancer

Axillary lymph nodes are kidney bean-shaped organs in the underarm area and are part of the lymphatic system. The interior of the lymph nodes contain lymphocytes and macrophages in abundance. The lymph nodes receive an extracellular fluid called lymph that circulates in the body and helps cleanse the blood vessels and tissues.

Lymph nodes act as filters of the lymph. Lymph from different tissues enters and drains away through the lymph nodes, where the macrophages and T-lymphocytes attack and destroy the tumor cells and pathogens. Post filtration, the lymph is returned to the blood stream for circulation as blood plasma. Thus, the lymph nodes function as filters in the lymphatic system and eliminate harmful substances from our body.

Drawing of female breast lymph drainage - Image Copyright: Blamb / Shutterstock
Drawing of female breast lymph drainage - Image Copyright: Blamb / Shutterstock

Role of Lymph Nodes in Cancer

Breast cancer often spreads to the axillary lymph nodes, thus taking the cancer cells to other parts of the body. Since the lymph nodes filter out harmful substances, they are usually examined to detect the presence of cancer cells that have passed through the node on their way to reach other parts of the body. During breast removal surgery, the lymph nodes are often dissected by surgeons to study the extent that cancer has spread. This is known as axillary lymph node dissection.

Axillary lymph node dissection was first used as part of breast cancer treatment in the 18th century. Since then axillary dissection has become a standard procedure used for staging of the axilla and treatment of breast cancer patients.

Positive and negative lymph nodes indicate the presence and absence of tumor cells in the lymph nodes and are one of the key indicators of the type of treatment required for a particular patient. Lymph node dissection helps remove cancer cells from the nodes, thus preventing cancer metastasis to a great extent. Patients in the early stages of breast cancer have a 30-40% chance of having positive axillary nodes.

If the cancer has spread to the axillary lymph nodes, the surgeon will recommend an axillary node dissection. The number of affected nodes varies from one patient to another, and so the decision is largely based on site of the cancer and not the number of positive nodes.

Many studies proved that axillary lymph node dissection helps in local control of the disease, thus improving overall survival of cancer patients. The cancer recurrence rate post axillary dissection was shown to be less than 2%. Hence, the staging of the axilla is an important step in the treatment of breast cancer. The status of axillary lymph node is a key prognostic variable in individuals with early stage breast carcinoma. The number of positive nodes also has prognostic importance.

Although removal of lymph nodes reduces the risk of cancer spreading to other body parts, it cannot destroy the cancer cells that may have already spread to other parts. However, the involvement of lymph nodes gives important insights into the nature and stage of the cancer and thus aids doctors in developing a customized treatment plan for a patient.

Levels of Axillary Nodes and Dissection

Axillary lymph nodes are classified into three levels including low axilla, mid axilla, and high axilla. Based on which level of axillary nodes is affected, the surgeon performs various levels of axillary dissection. In a majority of cases, level I or II nodes are removed if the sentinel node is positive or if there is a cancerous node present in the armpit. Women with invasive breast cancer usually undergo axillary dissection along with a mastectomy.

References

Further Reading

Last Updated: Feb 26, 2019

Susha Cheriyedath

Written by

Susha Cheriyedath

Susha is a scientific communication professional holding a Master's degree in Biochemistry, with expertise in Microbiology, Physiology, Biotechnology, and Nutrition. After a two-year tenure as a lecturer from 2000 to 2002, where she mentored undergraduates studying Biochemistry, she transitioned into editorial roles within scientific publishing. She has accumulated nearly two decades of experience in medical communication, assuming diverse roles in research, writing, editing, and editorial management.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Cheriyedath, Susha. (2019, February 26). Axillary Lymph Nodes and Breast Cancer. News-Medical. Retrieved on November 24, 2024 from https://www.news-medical.net/health/Axillary-Lymph-Nodes-and-Breast-Cancer.aspx.

  • MLA

    Cheriyedath, Susha. "Axillary Lymph Nodes and Breast Cancer". News-Medical. 24 November 2024. <https://www.news-medical.net/health/Axillary-Lymph-Nodes-and-Breast-Cancer.aspx>.

  • Chicago

    Cheriyedath, Susha. "Axillary Lymph Nodes and Breast Cancer". News-Medical. https://www.news-medical.net/health/Axillary-Lymph-Nodes-and-Breast-Cancer.aspx. (accessed November 24, 2024).

  • Harvard

    Cheriyedath, Susha. 2019. Axillary Lymph Nodes and Breast Cancer. News-Medical, viewed 24 November 2024, https://www.news-medical.net/health/Axillary-Lymph-Nodes-and-Breast-Cancer.aspx.

Comments

  1. Alicia Francis Alicia Francis South Africa says:

    Hi Susha

    Based on the above information. Please advise.
    I have bilateral axillary lymph nodes. One is 23mm and the other is 19mm. I've seen so many doctors, none has referred me for a biopsy. I've done mammograms and ultra sounds..it shows cyst. The other report says dense fibrograndular tissue noted in breast.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI models redefine TIL scoring in breast cancer but face challenges in real-world validation